These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9890001)

  • 1. RET proto-oncogene: role in kidney development and molecular pathology.
    Salomon R; Attie T; Amiel J; Pelet A; Niaudet P; Lyonnet S
    Adv Nephrol Necker Hosp; 1998; 28():401-17. PubMed ID: 9890001
    [No Abstract]   [Full Text] [Related]  

  • 2. Japanese patients with sporadic Hirschsprung: mutation analysis of the receptor tyrosine kinase proto-oncogene, endothelin-B receptor, endothelin-3, glial cell line-derived neurotrophic factor and neurturin genes: a comparison with similar studies.
    Sakai T; Nirasawa Y; Itoh Y; Wakizaka A
    Eur J Pediatr; 2000 Mar; 159(3):160-7. PubMed ID: 10664228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of the development of human disease caused by RET mutations.
    Romeo G
    Jpn J Cancer Res; 1997 Jan; 88(1):Inside front cover. PubMed ID: 9045887
    [No Abstract]   [Full Text] [Related]  

  • 4. Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.
    Carlomagno F; Melillo RM; Visconti R; Salvatore G; De Vita G; Lupoli G; Yu Y; Jing S; Vecchio G; Fusco A; Santoro M
    Endocrinology; 1998 Aug; 139(8):3613-9. PubMed ID: 9681515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular basis of Hirschsprung disease].
    Inoue M; Okada A
    Nihon Rinsho; 1998 Jan; 56(1):249-57. PubMed ID: 9465697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient.
    Angrist M; Bolk S; Halushka M; Lapchak PA; Chakravarti A
    Nat Genet; 1996 Nov; 14(3):341-4. PubMed ID: 8896568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease.
    Borrego S; Eng C; Sánchez B; Sáez ME; Navarro E; Antiñolo G
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3361-4. PubMed ID: 9745455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors.
    Marsh DJ; Zheng Z; Arnold A; Andrew SD; Learoyd D; Frilling A; Komminoth P; Neumann HP; Ponder BA; Rollins BJ; Shapiro GI; Robinson BG; Mulligan LM; Eng C
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3025-8. PubMed ID: 9284737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital central hypoventilation syndrome: a novel mutation of the RET gene in an isolated case.
    Kanai M; Numakura C; Sasaki A; Shirahata E; Akaba K; Hashimoto M; Hasegawa H; Shirasawa S; Hayasaka K
    Tohoku J Exp Med; 2002 Apr; 196(4):241-6. PubMed ID: 12086152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes and Hirschsprung disease.
    Smith DP; Eng C; Ponder BA
    J Cell Sci Suppl; 1994; 18():43-9. PubMed ID: 7883791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GDNF-RET signalling partnership.
    Robertson K; Mason I
    Trends Genet; 1997 Jan; 13(1):1-3. PubMed ID: 9009838
    [No Abstract]   [Full Text] [Related]  

  • 12. Co-segregation of MEN2 and Hirschsprung's disease: the same mutation of RET with both gain and loss-of-function?
    Takahashi M; Iwashita T; Santoro M; Lyonnet S; Lenoir GM; Billaud M
    Hum Mutat; 1999; 13(4):331-6. PubMed ID: 10220148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic aspects of Hirschsprung's disease.
    Kusafuka T; Puri P
    Semin Pediatr Surg; 1998 Aug; 7(3):148-55. PubMed ID: 9718652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of development of multiple endocrine neoplasia type 2 and Hirschsprung's disease by ret mutations.
    Takahashi M; Asai N; Iwashita T; Murakami H; Ito S
    Recent Results Cancer Res; 1998; 154():229-36. PubMed ID: 10027003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.
    Mulligan LM; Ponder BA
    J Clin Endocrinol Metab; 1995 Jul; 80(7):1989-95. PubMed ID: 7608246
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic analysis of RET, GFR alpha 1 and GDNF genes in Spanish families with multiple endocrine neoplasia type 2A.
    Gil L; Azañedo M; Pollán M; Cristobal E; Arribas B; García-Albert L; García-Sáiz A; Maestro ML; Torres A; Menárguez J; Rojas JM
    Int J Cancer; 2002 May; 99(2):299-304. PubMed ID: 11979448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic variation in a family with mutations in two Hirschsprung-related genes (RET and endothelin receptor B).
    Svensson PJ; Anvret M; Molander ML; Nordenskjöld A
    Hum Genet; 1998 Aug; 103(2):145-8. PubMed ID: 9760196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RET in human development and oncogenesis.
    Edery P; Eng C; Munnich A; Lyonnet S
    Bioessays; 1997 May; 19(5):389-95. PubMed ID: 9174404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RET receptor: function in development and dysfunction in congenital malformation.
    Manié S; Santoro M; Fusco A; Billaud M
    Trends Genet; 2001 Oct; 17(10):580-9. PubMed ID: 11585664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET mutations in multiple endocrine neoplasia type 2 and Hirschsprung disease.
    Reynolds LF; Eng C
    Curr Opin Pediatr; 1995 Dec; 7(6):702-9. PubMed ID: 8776023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.